Nav1 Channel

1

Aydar E et al. Sigma-1 receptors modulate neonatal Nav1.5 ion channels in breast cancer cell lines.
Eur. Biophys. J., 2016 May 9 , ().

2

Yang J et al. FGF13 modulates the gating properties of the cardiac sodium channel Nav1.5 in an isoform-specific manner.
Channels (Austin), 2016 May 31 , (1-11).

3

Hirano-Iwata A et al. Reconstitution of Human Ion Channels into Solvent-free Lipid Bilayers Enhanced by Centrifugal Forces.
Biophys. J., 2016 May 24 , 110 (2207-15).

4

Zeng H et al. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
J Pharmacol Toxicol Methods, 2016 May 21 , ().

5

Rosberg MR et al. Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B.
Neurobiol. Dis., 2016 May 20 , 93 (201-214).

6

Ali SR et al. Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6.
J. Biol. Chem., 2016 May 20 , 291 (11268-84).

7

Mulcahy JV et al. Synthesis of the Paralytic Shellfish Poisons (+)-Gonyautoxin 2, (+)-Gonyautoxin 3, and (+)-11,11-Dihydroxysaxitoxin.
J. Am. Chem. Soc., 2016 May 11 , 138 (5994-6001).

8

Schilling JM et al. Electrophysiology and metabolism of caveolin-3-overexpressing mice.
Basic Res. Cardiol., 2016 May , 111 (28).

9

Cheng LJ et al. Effects of Fluvastatin on Characteristics of Stellate Ganglion Neurons in a Rabbit Model of Myocardial Ischemia.
Chin. Med. J., 2016 May , 129 (549-56).

10

Gupta B et al. Antinociceptive properties of shikonin: in vitro and in vivo studies.
Can. J. Physiol. Pharmacol., 2016 Mar 6 , (1-9).

11

Patel D et al. Computational Study of Binding of μ-Conotoxin GIIIA to Bacterial Sodium Channels NaVAb and NaVRh.
Biochemistry, 2016 Mar 29 , 55 (1929-38).

12

Tao H et al. Molecular determinant for the tarantula toxin Jingzhaotoxin-I slowing the fast inactivation of voltage-gated sodium channels.
Toxicon, 2016 Mar 1 , 111 (13-21).

13

Rogers M et al. Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening.
Assay Drug Dev Technol, 2016 Mar , 14 (109-30).

14

Chambers C et al. High-Throughput Screening of NaV1.7 Modulators Using a Giga-Seal Automated Patch Clamp Instrument.
Assay Drug Dev Technol, 2016 Mar , 14 (93-108).

15

Henriques ST et al. Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes is a Prerequisite for its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.
J. Biol. Chem., 2016 Jun 16 , ().

16

Xu J et al. Peimine, a main active ingredient of Fritillaria, exhibits anti-inflammatory and pain suppression properties at the cellular level.
Fitoterapia, 2016 Jun , 111 (1-6).

17

Du Y et al. β1-Adrenergic blocker bisoprolol reverses down-regulated ion channels in sinoatrial node of heart failure rats.
J. Physiol. Biochem., 2016 Jun , 72 (293-302).

18

Arias HR et al. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
Int. J. Biochem. Cell Biol., 2016 Jul , 76 (19-30).

19

Zaklyazminskaya E et al. The role of mutations in the SCN5A gene in cardiomyopathies.
Biochim. Biophys. Acta, 2016 Jul , 1863 (1799-805).

20

Sottas V et al. Negative-dominance phenomenon with genetic variants of the cardiac sodium channel Nav1.5.
Biochim. Biophys. Acta, 2016 Jul , 1863 (1791-8).

21

Green BR et al. Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin μO§-GVIIJ.
J. Biol. Chem., 2016 Jan 27 , ().

22

Cui HL et al. Catalytic asymmetric hetero-Diels-Alder reactions of enones with isatins to access functionalized spirooxindole tetrahydropyrans: scope, derivatization, and discovery of bioactives.
Org. Biomol. Chem., 2016 Jan 27 , 14 (1777-83).

23

Wang HG et al. A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.
J. Mol. Cell. Cardiol., 2016 Jan 19 , 92 (52-62).

24

Tarvin RD et al. Convergent Substitutions in a Sodium Channel Suggest Multiple Origins of Toxin Resistance in Poison Frogs.
Mol. Biol. Evol., 2016 Jan 18 , ().

25

He B et al. Effects of the β1 auxiliary subunit on modification of Rat Na(v)1.6 sodium channels expressed in HEK293 cells by the pyrethroid insecticides tefluthrin and deltamethrin.
Toxicol. Appl. Pharmacol., 2016 Jan 15 , 291 (58-69).

26

Habbout K et al. A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.
Neurology, 2016 Jan 12 , 86 (161-9).

27

Mohammed FH et al. Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells.
Int. J. Oncol., 2016 Jan , 48 (73-83).

28

Horvath GA et al. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
Mol. Genet. Metab., 2016 Jan , 117 (42-8).

29

Stueber T et al. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity.
Anesthesiology, 2016 Feb 9 , ().

30

Han C et al. Sodium channel Nav1.8: Emerging links to human disease.
Neurology, 2016 Feb 2 , 86 (473-83).

31

Roostaei T et al. Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Neurology, 2016 Feb 2 , 86 (410-7).

32

Murray JK et al. Single Residue Substitutions That Confer NaV Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
J. Med. Chem., 2016 Feb 18 , ().

33

Benned-Jensen T et al. Live Imaging of Kv7.2/7.3 Cell Surface Dynamics at the Axon Initial Segment: High Steady-State Stability and Calpain-Dependent Excitotoxic Downregulation Revealed.
J. Neurosci., 2016 Feb 17 , 36 (2261-6).

34

Kim KX et al. Maturation of NaV and KV Channel Topographies in the Auditory Nerve Spike Initiator before and after Developmental Onset of Hearing Function.
J. Neurosci., 2016 Feb 17 , 36 (2111-8).

35

Poulet C et al. Altered physiological functions and ion currents in atrial fibroblasts from patients with chronic atrial fibrillation.
Physiol Rep, 2016 Feb , 4 ().

36

Ye P et al. Functional up-regulation of Nav1.8 sodium channel on dorsal root ganglia neurons contributes to the induction of scorpion sting pain.
Acta Biochim. Biophys. Sin. (Shanghai), 2016 Feb , 48 (132-44).

37

Murenzi E et al. Evaluation of microtransplantation of rat brain neurolemma into Xenopus laevis oocytes as a technique to study the effect of neurotoxicants on endogenous voltage-sensitive ion channels.
Neurotoxicology, 2016 Apr 7 , ().

38

Crumb WJ et al. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
J Pharmacol Toxicol Methods, 2016 Apr 6 , ().

39

Branch SY et al. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
J. Neurosci., 2016 Apr 6 , 36 (4026-37).

40

Shcherbatko A et al. Engineering Highly Potent and Selective Microproteins Against Nav1.7 Sodium Channel for Treatment of Pain.
J. Biol. Chem., 2016 Apr 22 , ().

41

Frost JM et al. Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
J. Med. Chem., 2016 Apr 14 , 59 (3373-91).

42

Nassal DM et al. Myocardial KChIP2 Expression in Guinea Pig Resolves an Expanded Electrophysiologic Role.
PLoS ONE, 2016 , 11 (e0146561).

43

Zhang H et al. Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels.
Elife, 2016 , 5 ().

44

Lazcano-Pérez F et al. Activity of Palythoa caribaeorum Venom on Voltage-Gated Ion Channels in Mammalian Superior Cervical Ganglion Neurons.
Toxins (Basel), 2016 , 8 ().

45

Kubanek J et al. Ultrasound modulates ion channel currents.
Sci Rep, 2016 , 6 (24170).

46

Choi JI et al. α1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current.
PLoS ONE, 2016 , 11 (e0152355).

47

Alshammari MA et al. Improved Methods for Fluorescence Microscopy Detection of Macromolecules at the Axon Initial Segment.
Front Cell Neurosci, 2016 , 10 (5).

48

Leo-Macias A et al. Nanoscale visualization of functional adhesion/excitability nodes at the intercalated disc.
Nat Commun, 2016 , 7 (10342).

49

Wang X et al. Characterization of Specific Roles of Sodium Channel Subtypes in Regional Anesthesia.
Reg Anesth Pain Med, 2015 Sep-Oct , 40 (599-604).

50

Eberhardt E et al. Pattern of Functional TTX-Resistant Sodium Channels Reveals a Developmental Stage of Human iPSC- and ESC-Derived Nociceptors.
Stem Cell Reports, 2015 Sep 8 , 5 (305-13).

51

Ji RR Neuroimmune interactions in itch: Do chronic itch, chronic pain, and chronic cough share similar mechanisms?
Pulm Pharmacol Ther, 2015 Sep 6 , ().

52

Salas MM et al. Tetrodotoxin suppresses thermal hyperalgesia and mechanical allodynia in a rat full thickness thermal injury pain model.
Neurosci. Lett., 2015 Sep 28 , 607 (108-113).

53

Nutter TJ et al. A delayed chronic pain like condition with decreased Kv channel activity in a rat model of Gulf War Illness pain syndrome.
Neurotoxicology, 2015 Sep 26 , 51 (67-79).

54

Remacle AG et al. Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling.
J. Biol. Chem., 2015 Sep 18 , 290 (22939-44).

55

Neshatian L et al. Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.
Am. J. Physiol. Gastrointest. Liver Physiol., 2015 Sep 15 , 309 (G506-12).

56

Kurowski P et al. Muscarinic receptor control of pyramidal neuron membrane potential in the medial prefrontal cortex (mPFC) in rats.
Neuroscience, 2015 Sep 10 , 303 (474-88).

57

Dib-Hajj SD et al. NaV1.9: a sodium channel linked to human pain.
Nat. Rev. Neurosci., 2015 Sep , 16 (511-9).

58

Aktas CC et al. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
Acta Biochim. Biophys. Sin. (Shanghai), 2015 Sep , 47 (680-6).

59

Li G et al. Positive shift of Nav1.8 current inactivation curve in injured neurons causes neuropathic pain following chronic constriction injury.
Mol Med Rep, 2015 Sep , 12 (3583-90).

60

Namer B et al. Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7.
Pain, 2015 Sep , 156 (1637-46).

61

Estacion M et al. Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation.
J. Neurophysiol., 2015 Sep , 114 (1554-64).

62

Musa H et al. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
Proc. Natl. Acad. Sci. U.S.A., 2015 Oct 6 , 112 (12528-33).

63

Endo R et al. Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC.
Drug Res (Stuttg), 2015 Oct 19 , ().

64

Hao W et al. Design, synthesis and structure-activity relationship of indoxacarb analogs as voltage-gated sodium channel blocker.
Bioorg. Med. Chem. Lett., 2015 Oct 15 , 25 (4576-9).

65

Patel R et al. Ionic Mechanisms of Spinal Neuronal Cold Hypersensitivity in Ciguatera.
Eur. J. Neurosci., 2015 Oct 10 , ().

66

Klint JK et al. Rational engineering defines a molecular switch that is essential for activity of spider-venom peptides against the analgesics target NaV1.7.
Mol. Pharmacol., 2015 Oct 1 , ().

67

Nicole S et al. Skeletal muscle sodium channelopathies.
Curr. Opin. Neurol., 2015 Oct , 28 (508-514xs).

68

Detta N et al. The multi-faceted aspects of the complex cardiac Nav1.5 protein in membrane function and pathophysiology.
Biochim. Biophys. Acta, 2015 Oct , 1854 (1502-9).

69

Torbergsen T et al. Painful cramps and giant myotonic discharges in a family with the Nav1.4-G1306A mutation.
Muscle Nerve, 2015 Oct , 52 (680-3).

70

Murray JK et al. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
Bioorg. Med. Chem. Lett., 2015 Nov 1 , 25 (4866-71).

71

Zheng G et al. Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways.
Exp. Neurol., 2015 Nov , 273 (301-11).

72

Gawali VS et al. Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na⁺ Channels.
Mol. Pharmacol., 2015 Nov , 88 (866-79).

73

Liu C et al. Amyloid precursor protein enhances Nav1.6 sodium channel cell surface expression.
J. Biol. Chem., 2015 May 8 , 290 (12048-57).

74

Hamada MS et al. Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
J. Neurosci., 2015 May 6 , 35 (7272-86).

75

Han Z et al. The effects of A-803467 on cardiac Nav1.5 channels.
Eur. J. Pharmacol., 2015 May 5 , 754 (52-60).

76

Lu VB et al. A 3.7 kb fragment of the mouse Scn10a gene promoter directs neural crest but not placodal lineage EGFP expression in a transgenic animal.
J. Neurosci., 2015 May 20 , 35 (8021-34).

77

Emery EC et al. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
J. Neurosci., 2015 May 20 , 35 (7674-81).

78

Lolignier S et al. The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.
Cell Rep, 2015 May 19 , 11 (1067-78).

79

Chahine M Gating pore current is a novel biophysical defect of Nav1.5 mutations associated with unusual cardiac arrhythmias and dilation.
Future Cardiol, 2015 May , 11 (287-91).

80

Woods CG et al. The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P.
Eur. J. Hum. Genet., 2015 May , 23 (561-3).

81

Zhu JF et al. Novel heterozygous mutation c.4282G>T in the SCN5A gene in a family with Brugada syndrome.
Exp Ther Med, 2015 May , 9 (1639-1645).

82

Kalume F et al. Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome.
Neurobiol. Dis., 2015 May , 77 (141-54).

83

Marionneau C et al. Regulation of the cardiac Na+ channel NaV1.5 by post-translational modifications.
J. Mol. Cell. Cardiol., 2015 May , 82 (36-47).

84

Tsai MS et al. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Neurobiol. Dis., 2015 May , 77 (35-48).

85

Blanchard MG et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
J. Med. Genet., 2015 May , 52 (330-7).

86

Wildburger NC et al. Quantitative proteomics reveals protein-protein interactions with fibroblast growth factor 12 as a component of the voltage-gated sodium channel 1.2 (nav1.2) macromolecular complex in Mammalian brain.
Mol. Cell Proteomics, 2015 May , 14 (1288-300).

87

Liu GX et al. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
Heart Rhythm, 2015 May , 12 (1036-45).

88

Stadler T et al. Erythromelalgia mutation Q875E Stabilizes the activated state of sodium channel Nav1.7.
J. Biol. Chem., 2015 Mar 6 , 290 (6316-25).

89

Tan BY et al. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
Europace, 2015 Mar 31 , ().

90

Han C et al. Human Nav1.8: enhanced persistent and ramp currents contribute to distinct firing properties of human DRG neurons.
J. Neurophysiol., 2015 Mar 18 , (jn.00113.2015).

91

Mishra S et al. Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts.
J. Physiol. (Lond.), 2015 Mar 15 , 593 (1409-27).

92

Murray JK et al. Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel.
J. Med. Chem., 2015 Mar 12 , 58 (2299-314).

93

Ossola D et al. Force-controlled patch clamp of beating cardiac cells.
Nano Lett., 2015 Mar 11 , 15 (1743-50).

94

Tigerholm J et al. C-fiber recovery cycle supernormality depends on ion concentration and ion channel permeability.
Biophys. J., 2015 Mar 10 , 108 (1057-71).

95

Gazina EV et al. 'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour.
Hum. Mol. Genet., 2015 Mar 1 , 24 (1457-68).

96

Kong W et al. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability.
Epilepsia, 2015 Mar , 56 (431-8).

97

Yan Z et al. Expression and functional role of Nav1.9 sodium channel in cartwheel cells of the dorsal cochlear nucleus.
Mol Med Rep, 2015 Mar , 11 (1833-6).

98

Bechi G et al. Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum.
Neurobiol. Dis., 2015 Mar , 75 (100-14).

99

Rahman W et al. Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat.
Neuroscience, 2015 Jun 4 , 295 (103-16).

100

Zhang MM et al. Probing the Redox States of Sodium Channel Cysteines at the Binding Site of μO§-Conotoxin GVIIJ.
Biochemistry, 2015 Jun 30 , 54 (3911-20).

101

Hoeijmakers JG et al. Painful peripheral neuropathy and sodium channel mutations.
Neurosci. Lett., 2015 Jun 2 , 596 (51-9).

102

Du Y et al. Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling.
ACS Chem Neurosci, 2015 Jun 17 , 6 (871-8).

103

Behr ER et al. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.
Cardiovasc. Res., 2015 Jun 1 , 106 (520-9).

104

Mercier A et al. Nav1.5 channels can reach the plasma membrane through distinct N-glycosylation states.
Biochim. Biophys. Acta, 2015 Jun , 1850 (1215-23).

105

Ye P et al. Scorpion toxin BmK I directly activates Nav1.8 in primary sensory neurons to induce neuronal hyperexcitability in rats.
Protein Cell, 2015 Jun , 6 (443-52).

106

Fukasawa T et al. A case of recurrent encephalopathy with SCN2A missense mutation.
Brain Dev., 2015 Jun , 37 (631-4).

107

Wannous R et al. Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities.
Pflugers Arch., 2015 Jun , 467 (1249-59).

108

Stroemlund LW et al. Gap junctions - guards of excitability.
Biochem. Soc. Trans., 2015 Jun , 43 (508-12).

109

Huang Y et al. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
Peptides, 2015 Jun , 68 (175-82).

110

Han C et al. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Neuromolecular Med., 2015 Jun , 17 (158-69).

111

Winkel BG et al. The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome.
Heart Rhythm, 2015 Jun , 12 (1241-9).

112

Daimi H et al. Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.
Heart Rhythm, 2015 Jun , 12 (1333-42).

113

Cai T et al. Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels.
Peptides, 2015 Jun , 68 (148-56).

114

Coronas FI et al. Biochemical and physiological characterization of a new Na(+)-channel specific peptide from the venom of the Argentinean scorpion Tityus trivittatus.
Peptides, 2015 Jun , 68 (11-6).

115

Xu M et al. An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels.
J. Biol. Chem., 2015 Jul 3 , 290 (16619-32).

116

Talbot S et al. Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation.
Neuron, 2015 Jul 15 , 87 (341-54).

117

Torregrosa R et al. Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels.
Bioorg. Med. Chem., 2015 Jul 1 , 23 (3655-66).

118

Chow CY et al. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Toxins (Basel), 2015 Jul , 7 (2494-513).

119

Slowik D et al. Benchmarking the stability of human detergent-solubilised voltage-gated sodium channels for structural studies using eel as a reference.
Biochim. Biophys. Acta, 2015 Jul , 1848 (1545-51).

120

Wang ZJ et al. Inhibition of Nav1.7 channels by methyl eugenol as a mechanism underlying its antinociceptive and anesthetic actions.
Acta Pharmacol. Sin., 2015 Jul , 36 (791-9).

121

Pucca MB et al. Revealing the Function and the Structural Model of Ts4: Insights into the "Non-Toxic" Toxin from Tityus serrulatus Venom.
Toxins (Basel), 2015 Jul , 7 (2534-50).

122

Wang M et al. [Dynamic expressions of Nav1.2 and Nav1.6 in hippocampal CA3 region of epileptic rats].
Zhonghua Yi Xue Za Zhi, 2015 Jan 6 , 95 (61-5).

123

Zhang J et al. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
Eur. J. Pharmacol., 2015 Jan 5 , 746 (333-43).

124

Chong E et al. Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.
Heart Rhythm, 2015 Jan 30 , ().

125

Fukuoka T et al. De novo expression of Nav1.7 in injured putative proprioceptive afferents: Multiple tetrodotoxin-sensitive sodium channels are retained in the rat dorsal root after spinal nerve ligation.
Neuroscience, 2015 Jan 22 , 284 (693-706).

126

Wagnon JL et al. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.
Hum. Mol. Genet., 2015 Jan 15 , 24 (506-15).

127

Lynch SM et al. Dibenzazepines and dibenzoxazepines as sodium channel blockers.
Bioorg. Med. Chem. Lett., 2015 Jan 1 , 25 (43-7).

128

Lynch SM et al. N-Aryl azacycles as novel sodium channel blockers.
Bioorg. Med. Chem. Lett., 2015 Jan 1 , 25 (48-52).

129

Saber S et al. Complex genetic background in a large family with Brugada syndrome.
Physiol Rep, 2015 Jan 1 , 3 ().

130

Kirchhof P et al. First report on an inotropic peptide activating tetrodotoxin-sensitive, "neuronal" sodium currents in the heart.
Circ Heart Fail, 2015 Jan , 8 (79-88).

131

Stoetzer C et al. Methadone is a local anaesthetic-like inhibitor of neuronal Na+ channels and blocks excitability of mouse peripheral nerves.
Br J Anaesth, 2015 Jan , 114 (110-20).

132

Zhang F et al. Natural mutations change the affinity of μ-theraphotoxin-Hhn2a to voltage-gated sodium channels.
Toxicon, 2015 Jan , 93 (24-30).

133

Rubinstein M et al. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
Neurobiol. Dis., 2015 Jan , 73 (106-17).

134

Sato T et al. Glial reaction in the spinal cord of the degenerating muscle mouse (Scn8a (dmu)).
Neurochem. Res., 2015 Jan , 40 (124-9).

135

Feng B et al. Experimental and computational evidence for an essential role of NaV1.6 in spike initiation at stretch-sensitive colorectal afferent endings.
J. Neurophysiol., 2015 Feb 4 , (jn.00717.2014).

136

Larsen J et al. The phenotypic spectrum of SCN8A encephalopathy.
Neurology, 2015 Feb 3 , 84 (480-9).

137

Vandael DH et al. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.
J. Physiol. (Lond.), 2015 Feb 15 , 593 (905-27).

138

Moreau A et al. Gating pore currents are defects in common with two Nav1.5 mutations in patients with mixed arrhythmias and dilated cardiomyopathy.
J. Gen. Physiol., 2015 Feb , 145 (93-106).

139

Beltran-Alvarez P et al. Interplay between R513 methylation and S516 phosphorylation of the cardiac voltage-gated sodium channel.
Amino Acids, 2015 Feb , 47 (429-34).

140

Ednie AR et al. Sialic acids attached to N- and O-glycans within the Nav1.4 D1S5-S6 linker contribute to channel gating.
Biochim. Biophys. Acta, 2015 Feb , 1850 (307-17).

141

Zhang H et al. Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.
Mol. Pharmacol., 2015 Feb , 87 (207-17).

142

Suter MR et al. p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder.
Anesthesiology, 2015 Feb , 122 (414-23).

143

Bi RY et al. A new hypothesis of sex-differences in temporomandibular disorders: estrogen enhances hyperalgesia of inflamed TMJ through modulating voltage-gated sodium channel 1.7 in trigeminal ganglion?
Med. Hypotheses, 2015 Feb , 84 (100-3).

144

Jabbari J et al. Common and rare variants in SCN10A modulate the risk of atrial fibrillation.
Circ Cardiovasc Genet, 2015 Feb , 8 (64-73).

145

Tikhonov DB et al. State-dependent inter-repeat contacts of exceptionally conserved asparagines in the inner helices of sodium and calcium channels.
Pflugers Arch., 2015 Feb , 467 (253-66).

146

Teramoto N et al. Selective blocking effects of 4,9-anhydrotetrodotoxin, purified from a crude mixture of tetrodotoxin analogues, on NaV1.6 channels and its chemical aspects.
Mar Drugs, 2015 Feb , 13 (984-95).

147

Zhu W et al. Molecular motions that shape the cardiac action potential: Insights from voltage clamp fluorometry.
Prog. Biophys. Mol. Biol., 2015 Dec 25 , ().

148

Obergrussberger A et al. Automated Patch Clamp Meets High-Throughput Screening: 384 Cells Recorded in Parallel on a Planar Patch Clamp Module.
J Lab Autom, 2015 Dec 23 , ().

149

Zaharieva IT et al. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.
Brain, 2015 Dec 22 , ().

150

Ahuja S et al. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.
Science, 2015 Dec 18 , 350 (aac5464).

151

Spencer NJ Switching off pain at the source: is this the end for opioid pain relief?
Pain Manag, 2015 Dec 17 , ().

152

Li N et al. Downregulation of the sodium channel Nav1.6 by potential transcriptomic deregulation may explain sensory deficits in critical illness neuropathy.
Life Sci., 2015 Dec 15 , 143 (231-6).

153

Veerman CC et al. The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.
Gene, 2015 Dec 1 , 573 (177-87).

154

Huang X et al. Age-dependent alterations of voltage-gated Na(+) channel isoforms in rat sinoatrial node.
Mech. Ageing Dev., 2015 Dec , 152 (80-90).

155

Szabat M et al. High-content screening identifies a role for Na(+) channels in insulin production.
R Soc Open Sci, 2015 Dec , 2 (150306).

156

Kancherla AK et al. A Disulfide Stabilized β-Sandwich Defines the Structure of a New Cysteine Framework M-Superfamily Conotoxin.
ACS Chem. Biol., 2015 Aug 21 , 10 (1847-60).

157

Crestey F et al. Identification and electrophysiological evaluation of 2-methylbenzamide derivatives as Nav1.1 modulators.
ACS Chem Neurosci, 2015 Aug 19 , 6 (1302-8).

158

Glynn P et al. Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.
Circulation, 2015 Aug 18 , 132 (567-77).

159

Varga Z et al. Direct Measurement of Cardiac Na+ Channel Conformations Reveals Molecular Pathologies of Inherited Mutations.
Circ Arrhythm Electrophysiol, 2015 Aug 17 , ().

160

Rubinstein M et al. Dissecting the phenotypes of Dravet syndrome by gene deletion.
Brain, 2015 Aug , 138 (2219-33).

161

Cardoso FC et al. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Mol. Pharmacol., 2015 Aug , 88 (291-303).

162

Biet M et al. Prolongation of action potential duration and QT interval during epilepsy linked to increased contribution of neuronal sodium channels to cardiac late Na+ current: potential mechanism for sudden death in epilepsy.
Circ Arrhythm Electrophysiol, 2015 Aug , 8 (912-20).

163

Potet F et al. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Circ Arrhythm Electrophysiol, 2015 Aug , 8 (933-41).

164

Pucca MB et al. Electrophysiological characterization of the first Tityus serrulatus alpha-like toxin, Ts5: Evidence of a pro-inflammatory toxin on macrophages.
Biochimie, 2015 Aug , 115 (8-16).

165

Peigneur S et al. A gamut of undiscovered electrophysiological effects produced by Tityus serrulatus toxin 1 on NaV-type isoforms.
Neuropharmacology, 2015 Apr 7 , ().

166

Xie W et al. Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain.
Neuroscience, 2015 Apr 16 , 291 (317-30).

167

Guo F et al. Low-Mg(2+) treatment increases sensitivity of voltage-gated Na(+) channels to Ca(2+)/calmodulin-mediated modulation in cultured hippocampal neurons.
Am. J. Physiol., Cell Physiol., 2015 Apr 15 , 308 (C594-605).

168

Willis BC et al. Protein Assemblies of Sodium and Inward Rectifier Potassium Channels Control Cardiac Excitability and Arrhythmogenesis.
Am. J. Physiol. Heart Circ. Physiol., 2015 Apr 10 , (ajpheart.00176.2015).

169

Wilson MJ et al. Α- and β-subunit composition of voltage-gated sodium channels investigated with μ-conotoxins and the recently discovered μO§-conotoxin GVIIJ.
J. Neurophysiol., 2015 Apr 1 , 113 (2289-301).

170

Cannon SC Channelopathies of skeletal muscle excitability.
Compr Physiol, 2015 Apr , 5 (761-90).

171

James TF et al. The Nav1.2 channel is regulated by GSK3.
Biochim. Biophys. Acta, 2015 Apr , 1850 (832-44).

172

Zhang C et al. 17β-Estradiol increases persistent Na(+) current and excitability of AVPV/PeN Kiss1 neurons in female mice.
Mol. Endocrinol., 2015 Apr , 29 (518-27).

173

Chung G et al. Generation of resonance-dependent oscillation by mGluR-I activation switches single spiking to bursting in mesencephalic trigeminal sensory neurons.
Eur. J. Neurosci., 2015 Apr , 41 (998-1012).

174

Bugiardini E et al. SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype.
Neuromuscul. Disord., 2015 Apr , 25 (301-7).

175

Habib AM et al. Sodium channels and pain.
Handb Exp Pharmacol, 2015 , 227 (39-56).

176

Hsu WC et al. Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.
PLoS ONE, 2015 , 10 (e0117246).

177

Wang L et al. A mutation in the intracellular loop III/IV of mosquito sodium channel synergizes the effect of mutations in helix IIS6 on pyrethroid resistance.
Mol. Pharmacol., 2015 , 87 (421-9).

178

Iqbal SM et al. Differential Modulation of Fast Inactivation in Cardiac Sodium Channel Splice Variants by Fyn Tyrosine Kinase.
Cell. Physiol. Biochem., 2015 , 37 (825-37).

179

Matson DJ et al. Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain.
PLoS ONE, 2015 , 10 (e0138140).

180

Mahdavi S et al. Mechanism of Ion Permeation in Mammalian Voltage-Gated Sodium Channels.
PLoS ONE, 2015 , 10 (e0133000).

181

Hoffman-Zacharska D et al. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
Neurol. Neurochir. Pol., 2015 , 49 (258-66).

182

Yamanushi TT et al. Comparison of formaldehyde and methanol fixatives used in the detection of ion channel proteins in isolated rat ventricular myocytes by immunofluorescence labelling and confocal microscopy.
Folia Morphol. (Warsz), 2015 , 74 (258-61).

183

Stephens RF et al. Selectivity filters and cysteine-rich extracellular loops in voltage-gated sodium, calcium, and NALCN channels.
Front Physiol, 2015 , 6 (153).

184

Nelson M et al. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.
Mol. Cancer, 2015 , 14 (13).

185

Brun J et al. Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells.
PLoS ONE, 2015 , 10 (e0145153).

186

Obejero-Paz CA et al. Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk.
Sci Rep, 2015 , 5 (17623).

187

Nikolaidou T et al. Congestive Heart Failure Leads to Prolongation of the PR Interval and Atrioventricular Junction Enlargement and Ion Channel Remodelling in the Rabbit.
PLoS ONE, 2015 , 10 (e0141452).

188

Gu H et al. cAMP/PKA Pathways and S56 Phosphorylation Are Involved in AA/PGE2-Induced Increases in rNaV1.4 Current.
PLoS ONE, 2015 , 10 (e0140715).

189

Hu RM et al. Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis.
PLoS ONE, 2015 , 10 (e0124921).

190

Akin EJ et al. Preferential targeting of Nav1.6 voltage-gated Na+ Channels to the axon initial segment during development.
PLoS ONE, 2015 , 10 (e0124397).

191

Liu XL et al. Mutations of SCN4A gene cause different diseases: 2 case reports and literature review.
Channels (Austin), 2015 , 9 (82-7).

192

Tang C et al. Synergetic action of domain II and IV underlies persistent current generation in Nav1.3 as revealed by a tarantula toxin.
Sci Rep, 2015 , 5 (9241).

193

Han Z et al. Deletion of PDK1 causes cardiac sodium current reduction in mice.
PLoS ONE, 2015 , 10 (e0122436).

194

Gu XY et al. Dexmedetomidine inhibits Tetrodotoxin-resistant Nav1.8 sodium channel activity through Gi/o-dependent pathway in rat dorsal root ganglion neurons.
Mol Brain, 2015 , 8 (15).

195

Shields SD et al. Oral administration of PF-01247324, a subtype-selective Nav1.8 blocker, reverses cerebellar deficits in a mouse model of multiple sclerosis.
PLoS ONE, 2015 , 10 (e0119067).

196

Leipold E et al. Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.
Nat Commun, 2015 , 6 (10049).

197

Bao L Trafficking regulates the subcellular distribution of voltage-gated sodium channels in primary sensory neurons.
Mol Pain, 2015 , 11 (61).

198

Barbosa C et al. Navβ4 regulates fast resurgent sodium currents and excitability in sensory neurons.
Mol Pain, 2015 , 11 (60).

199

Wang L et al. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Cell. Physiol. Biochem., 2015 , 36 (2250-62).

200

Sun LH et al. MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Navβ2 protein coding region in rat with chronic brain hypoperfusion.
Mol Neurodegener, 2015 , 10 (36).

201

Pal D et al. Reduced Nav1.6 Sodium Channel Activity in Mice Increases In Vivo Sensitivity to Volatile Anesthetics.
PLoS ONE, 2015 , 10 (e0134960).

202

Kharatmal SB et al. Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy.
Mini Rev Med Chem, 2015 , 15 (1134-47).

203

Patel RR et al. Human Nav1.6 Channels Generate Larger Resurgent Currents than Human Nav1.1 Channels, but the Navβ4 Peptide Does Not Protect Either Isoform from Use-Dependent Reduction.
PLoS ONE, 2015 , 10 (e0133485).

204

Chen W et al. Tumor necrosis factor-α enhances voltage-gated Na⁺ currents in primary culture of mouse cortical neurons.
J Neuroinflammation, 2015 , 12 (126).

205

Tan AM et al. Virus-Mediated Knockdown of Nav1.3 in Dorsal Root Ganglia of STZ-Induced Diabetic Rats Alleviates Tactile Allodynia.
Mol. Med., 2015 , 21 (544-52).

206

Camargos TS et al. The Scorpion Toxin Tf2 from Tityus fasciolatus Promotes Nav1.3 Opening.
PLoS ONE, 2015 , 10 (e0128578).

207

Wang Y et al. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
PLoS ONE, 2015 , 10 (e0128653).

208

Doran C et al. Mouse DRG Cell Line with Properties of Nociceptors.
PLoS ONE, 2015 , 10 (e0128670).

209

Koenig J et al. Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.
PLoS ONE, 2015 , 10 (e0128830).

210

Rice FL et al. Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.
Mol Pain, 2015 , 11 (26).

211

Chen YJ et al. Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A.
Mol. Neurobiol., 2015 , 51 (1263-70).

212

Mirams GR et al. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
J Pharmacol Toxicol Methods, 2014 Nov-Dec , 70 (246-54).

213

Sällström J et al. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: Heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
J Pharmacol Toxicol Methods, 2014 Jan-Feb , 69 (24-9).

214

Dusmez D et al. Effect of verapamil and lidocaine on TRPM and NaV1.9 gene expressions in renal ischemia-reperfusion.
Transplant. Proc., 2014 Jan-Feb , 46 (33-9).

215

King GF et al. No gain, no pain: NaV1.7 as an analgesic target.
ACS Chem Neurosci, 2014 Sep 17 , 5 (749-51).

216

Hien YE et al. CK2 accumulation at the axon initial segment depends on sodium channel Nav1.
FEBS Lett., 2014 Sep 17 , 588 (3403-8).

217

Sun S et al. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Bioorg. Med. Chem. Lett., 2014 Sep 15 , 24 (4397-401).

218

Huang J et al. Depolarized inactivation overcomes impaired activation to produce DRG neuron hyperexcitability in a Nav1.7 mutation in a patient with distal limb pain.
J. Neurosci., 2014 Sep 10 , 34 (12328-40).

219

Ho GD et al. Discovery of pyrrolo-benzo-1,4-diazines as potent Na(v)1.7 sodium channel blockers.
Bioorg. Med. Chem. Lett., 2014 Sep 1 , 24 (4110-3).

220

Ding T et al. Neural tissue engineering scaffold with sustained RAPA release relieves neuropathic pain in rats.
Life Sci., 2014 Sep 1 , 112 (22-32).

221

Frenz CT et al. NaV1.5 sodium channel window currents contribute to spontaneous firing in olfactory sensory neurons.
J. Neurophysiol., 2014 Sep 1 , 112 (1091-104).

222

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

223

Li T et al. Action potential initiation in neocortical inhibitory interneurons.
PLoS Biol., 2014 Sep , 12 (e1001944).

224

Estacion M et al. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
Neurobiol. Dis., 2014 Sep , 69 (117-23).

225

Horishita T et al. Neurosteroids allopregnanolone sulfate and pregnanolone sulfate have diverse effect on the α subunit of the neuronal voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 expressed in xenopus oocytes.
Anesthesiology, 2014 Sep , 121 (620-31).

226

Hirofuji S et al. Role of sodium channels in recovery of sciatic nerve-stretch injury in rats.
Muscle Nerve, 2014 Sep , 50 (425-30).

227

Cai B et al. Deletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and β3 subunit.
J. Mol. Cell. Cardiol., 2014 Sep , 74 (297-306).

228

Huang Y et al. The role of TNF-alpha/NF-kappa B pathway on the up-regulation of voltage-gated sodium channel Nav1.7 in DRG neurons of rats with diabetic neuropathy.
Neurochem. Int., 2014 Sep , 75 (112-9).

229

Sun S et al. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Pharm Pat Anal, 2014 Sep , 3 (509-21).

230

Korkosh VS et al. Folding similarity of the outer pore region in prokaryotic and eukaryotic sodium channels revealed by docking of conotoxins GIIIA, PIIIA, and KIIIA in a NavAb-based model of Nav1.4.
J. Gen. Physiol., 2014 Sep , 144 (231-44).

231

Meglič A et al. Painful micturition in a small child: an unusual clinical picture of paroxysmal extreme pain disorder.
Pediatr. Nephrol., 2014 Sep , 29 (1643-6).

232

Devigili G et al. Paroxysmal itch caused by gain-of-function Nav1.7 mutation.
Pain, 2014 Sep , 155 (1702-7).

233

Pappalardo LW et al. Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Neuroreport, 2014 Oct 22 , 25 (1208-15).

234

Gur Barzilai M et al. The specificity of Av3 sea anemone toxin for arthropods is determined at linker DI/SS2-S6 in the pore module of target sodium channels.
Biochem. J., 2014 Oct 15 , 463 (271-7).

235

Harrer JU et al. Neuropathic pain in two-generation twins carrying the sodium channel Nav1.7 functional variant R1150W.
Pain, 2014 Oct , 155 (2199-203).

236

Shi D et al. Reduction in dynamin-2 is implicated in ischaemic cardiac arrhythmias.
J. Cell. Mol. Med., 2014 Oct , 18 (1992-9).

237

Poulin H et al. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
Mol. Pharmacol., 2014 Oct , 86 (378-89).

238

Dhalla AK et al. Blockade of Na+ channels in pancreatic α-cells has antidiabetic effects.
Diabetes, 2014 Oct , 63 (3545-56).

239

Green BR et al. Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.
Future Med Chem, 2014 Oct , 6 (1677-98).

240

Boehringer T et al. SCN5A mutations and polymorphisms in patients with ventricular fibrillation during acute myocardial infarction.
Mol Med Rep, 2014 Oct , 10 (2039-44).

241

Foadi N et al. A combination of topical antiseptics for the treatment of sore throat blocks voltage-gated neuronal sodium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Oct , 387 (991-1000).

242

Hoeijmakers JG et al. Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?
Trends Mol Med, 2014 Oct , 20 (544-50).

243

Yue JX et al. Histamine upregulates Nav1.8 expression in primary afferent neurons via H2 receptors: involvement in neuropathic pain.
CNS Neurosci Ther, 2014 Oct , 20 (883-92).

244

Deuis JR et al. Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.
Neuro-oncology, 2014 Oct , 16 (1324-32).

245

Dong ZF et al. Transcription of the human sodium channel SCN1A gene is repressed by a scaffolding protein RACK1.
Mol. Neurobiol., 2014 Oct , 50 (438-48).

246

Hockley JR et al. Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.
Pain, 2014 Oct , 155 (1962-75).

247

Wang X et al. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Pacing Clin Electrophysiol, 2014 Oct , 37 (1349-56).

248

Liu M et al. Cardiac sodium channel mutations: why so many phenotypes?
Nat Rev Cardiol, 2014 Oct , 11 (607-15).

249

Shy D et al. Targeting the sodium channel NaV1.5 to specific membrane compartments of cardiac cells: not a simple task!
Circ. Res., 2014 Nov 7 , 115 (901-3).

250

Makara MA et al. Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo.
Circ. Res., 2014 Nov 7 , 115 (929-38).

251

Hedrich UB et al. Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation.
J. Neurosci., 2014 Nov 5 , 34 (14874-89).

252

Tan ZY et al. Protein kinase C enhances human sodium channel hNav1.7 resurgent currents via a serine residue in the domain III-IV linker.
FEBS Lett., 2014 Nov 3 , 588 (3964-9).

253

Zhao Z et al. Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs.
Anatol J Cardiol, 2014 Nov 11 , ().

254

Gillet L et al. Elucidating sodium channel NaV1.5 clustering in cardiac myocytes using super-resolution techniques.
Cardiovasc. Res., 2014 Nov 1 , 104 (231-3).

255

Chatin B et al. Dynamitin affects cell-surface expression of voltage-gated sodium channel Nav1.5.
Biochem. J., 2014 Nov 1 , 463 (339-49).

256

Zhang Q et al. Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression.
J. Physiol. (Lond.), 2014 Nov 1 , 592 (4677-96).

257

Agullo-Pascual E et al. Super-resolution imaging reveals that loss of the C-terminus of connexin43 limits microtubule plus-end capture and NaV1.5 localization at the intercalated disc.
Cardiovasc. Res., 2014 Nov 1 , 104 (371-81).

258

Savio-Galimberti E et al. SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation.
Cardiovasc. Res., 2014 Nov 1 , 104 (355-63).

259

Baskar S et al. Compound heterozygous mutations in the SCN5A-encoded Nav1.5 cardiac sodium channel resulting in atrial standstill and His-Purkinje system disease.
J. Pediatr., 2014 Nov , 165 (1050-2).

260

Waxman SG et al. Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
Lancet Neurol, 2014 Nov , 13 (1152-60).

261

Singh RR et al. Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm.
Pediatrics, 2014 Nov , 134 (e1447-50).

262

Beltran-Alvarez P et al. Identification of N-terminal protein acetylation and arginine methylation of the voltage-gated sodium channel in end-stage heart failure human heart.
J. Mol. Cell. Cardiol., 2014 Nov , 76 (126-9).

263

de Kovel CG et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
Epilepsy Res., 2014 Nov , 108 (1511-8).

264

Xu L et al. Functional characterization of two novel scorpion sodium channel toxins from Lychas mucronatus.
Toxicon, 2014 Nov , 90 (318-25).

265

McGlothlin JW et al. Parallel evolution of tetrodotoxin resistance in three voltage-gated sodium channel genes in the garter snake Thamnophis sirtalis.
Mol. Biol. Evol., 2014 Nov , 31 (2836-46).

266

Mansouri M et al. A novel nonsense mutation in SCN9A in a Moroccan child with congenital insensitivity to pain.
Pediatr. Neurol., 2014 Nov , 51 (741-4).

267

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

268

Baek JH et al. Reciprocal Changes in Phosphorylation and Methylation of Mammalian Brain Sodium Channels in Response to Seizures.
J. Biol. Chem., 2014 May 30 , 289 (15363-15373).

269

Kiss T et al. Down regulation of sodium channels in the central nervous system of hibernating snails.
Physiol. Behav., 2014 May 28 , 131 (93-8).

270

Baptista-Hon DT et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.
Br J Anaesth, 2014 May 22 , ().

271

Tan ZY et al. Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators.
J. Neurosci., 2014 May 21 , 34 (7190-7).

272

Gilchrist J et al. Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.
ACS Chem. Biol., 2014 May 16 , 9 (1204-12).

273

Klint JK et al. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.
Biochem. Pharmacol., 2014 May 15 , 89 (276-86).

274

Zhang YY et al. Characterization of functional ion channels in human cardiac c-kit+ progenitor cells.
Basic Res. Cardiol., 2014 May , 109 (407).

275

Wang GK et al. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Mol. Pharmacol., 2014 May , 85 (692-702).

276

Han C et al. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
J. Neurol. Neurosurg. Psychiatr., 2014 May , 85 (499-505).

277

Holzherr B et al. A gating model for wildtype and R1448H Nav1.4 channels in paramyotonia.
Acta Myol, 2014 May , 33 (22-33).

278

Pless SA et al. Asymmetric functional contributions of acidic and aromatic side chains in sodium channel voltage-sensor domains.
J. Gen. Physiol., 2014 May , 143 (645-56).

279

Dhamija R et al. Sleep abnormalities in children with Dravet syndrome.
Pediatr. Neurol., 2014 May , 50 (474-8).

280

Lin CR et al. Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats.
Eur. J. Neurosci., 2014 May , 39 (1682-9).

281

Garrison SR et al. A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons.
Pain, 2014 May , 155 (896-905).

282

Gui J et al. A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.
Curr. Biol., 2014 Mar 3 , 24 (473-83).

283

Zidar N et al. Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators.
Eur J Med Chem, 2014 Mar 3 , 74 (23-30).

284

Chen R et al. Mechanism of tetrodotoxin block and resistance in sodium channels.
Biochem. Biophys. Res. Commun., 2014 Mar 28 , 446 (370-4).

285

Thériault O et al. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Eur. J. Pharmacol., 2014 Mar 15 , 727 (158-66).

286

Kaczmarski JA et al. Investigating the size and dynamics of voltage-gated sodium channel fenestrations: A molecular dynamics study.
Channels (Austin), 2014 Mar 14 , 8 ().

287

Cerrone M et al. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
Circulation, 2014 Mar 11 , 129 (1092-103).

288

Okura D et al. The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.
Anesth. Analg., 2014 Mar , 118 (554-62).

289

Black JA et al. Nav1.9 expression in magnocellular neurosecretory cells of supraoptic nucleus.
Exp. Neurol., 2014 Mar , 253 (174-9).

290

Matalon D et al. Confirming an expanded spectrum of SCN2A mutations: a case series.
Epileptic Disord, 2014 Mar , 16 (13-8).

291

Elíes J et al. Inhibition of the cardiac Na⁺ channel Nav1.5 by carbon monoxide.
J. Biol. Chem., 2014 Jun 6 , 289 (16421-9).

292

Riol-Blanco L et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.
Nature, 2014 Jun 5 , 510 (157-61).

293

Lee JH et al. A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief.
Cell, 2014 Jun 5 , 157 (1393-404).

294

Boczek NJ et al. Characterization of SEMA3A-Encoded Semaphorin as a Naturally Occurring Kv4.3 Protein Inhibitor and its Contribution to Brugada Syndrome.
Circ. Res., 2014 Jun 24 , ().

295

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

296

Chen WN et al. Roles of ASIC3, TRPV1, and NaV1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgia.
Mol Pain, 2014 Jun 23 , 10 (40).

297

Xia L et al. Upregulation of Nav1.8 in Demyelinated Facial Nerves Might be Relevant to the Generation of Hemifacial Spasm.
J Craniofac Surg, 2014 Jun 2 , ().

298

Ben-Johny M et al. Conservation of Ca(2+)/Calmodulin Regulation across Na and Ca(2+) Channels.
Cell, 2014 Jun 19 , 157 (1657-70).

299

Lukacs P et al. Exploring the Structure of the Voltage-Gated Na+ Channel by an Engineered Drug Access Pathway to the Receptor Site for Local Anesthetics.
J. Biol. Chem., 2014 Jun 19 , ().

300

Nutter TJ et al. Persistent modification of Nav1.9 following chronic exposure to insecticides and pyridostigmine bromide.
Toxicol. Appl. Pharmacol., 2014 Jun 15 , 277 (298-309).

301

Bagnéris C et al. Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jun 10 , 111 (8428-33).

302

Lucas B et al. Contractile abnormalities of mouse muscles expressing hyperkalemic periodic paralysis mutant NaV1.4 channels do not correlate with Na+ influx or channel content.
Physiol. Genomics, 2014 Jun 1 , 46 (385-97).

303

Qi B et al. Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility.
Cardiovasc. Res., 2014 Jun 1 , 102 (480-6).

304

Sidaway P Pain: Gain-of-function Nav1.9 mutations are associated with painful peripheral neuropathy.
Nat Rev Neurol, 2014 Jun , 10 (306).

305

Bennett DL et al. Painful and painless channelopathies.
Lancet Neurol, 2014 Jun , 13 (587-99).

306

Zhang H et al. Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy.
Anesthesiology, 2014 Jun , 120 (1463-75).

307

Zeng T et al. A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding.
Hum. Genet., 2014 Jun , 133 (801-11).

308

Zeng Q et al. [Src family kinases affect the expression of Nav1.1 in spiral ganglion neurons].
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2014 Jun , 28 (789-92).

309

Yin G et al. Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms.
J Am Heart Assoc, 2014 Jun , 3 (e000996).

310

Huang J et al. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
Brain, 2014 Jun , 137 (1627-42).

311

Xing D et al. Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells.
Oncol. Rep., 2014 Jun , 31 (2692-700).

312

Foadi N et al. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
Anesth. Analg., 2014 Jun , 118 (1238-45).

313

Alday A et al. Ionic channels underlying the ventricular action potential in zebrafish embryo.
Pharmacol. Res., 2014 Jun , 84 (26-31).

314

Beyder A et al. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Gastroenterology, 2014 Jun , 146 (1659-68).

315

Ziyadeh-Isleem A et al. A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.
Heart Rhythm, 2014 Jun , 11 (1015-23).

316

Liang J et al. Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.
Neuromolecular Med., 2014 Jun , 16 (308-21).

317

Hu D et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.
J. Am. Coll. Cardiol., 2014 Jul 8 , 64 (66-79).

318

Shy D et al. PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.
Circulation, 2014 Jul 8 , 130 (147-60).

319

Tai C et al. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jul 29 , 111 (E3139-48).

320

Dybkova N et al. Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.
Cardiovasc. Res., 2014 Jul 1 , 103 (168-77).

321

Oliva MK et al. Physiological and genetic analysis of multiple sodium channel variants in a model of genetic absence epilepsy.
Neurobiol. Dis., 2014 Jul , 67 (180-90).

322

Riuró H et al. A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome.
Heart Rhythm, 2014 Jul , 11 (1202-9).

323

Lee JH et al. Metergoline inhibits the neuronal Nav1.2 voltage-dependent Na(+) channels expressed in Xenopus oocytes.
Acta Pharmacol. Sin., 2014 Jul , 35 (862-8).

324

Minett MS et al. Pain without nociceptors? Nav1.7-independent pain mechanisms.
Cell Rep, 2014 Jan 30 , 6 (301-12).

325

Barry J et al. Ankyrin-G directly binds to kinesin-1 to transport voltage-gated Na+ channels into axons.
Dev. Cell, 2014 Jan 27 , 28 (117-31).

326

Martins RP et al. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation.
Circulation, 2014 Jan 24 , ().

327

Eberhardt M et al. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
J. Biol. Chem., 2014 Jan 24 , 289 (1971-80).

328

Isensee J et al. Pain modulators regulate the dynamics of PKA-RII phosphorylation in subgroups of sensory neurons.
J. Cell. Sci., 2014 Jan 1 , 127 (216-29).

329

Kahlig KM et al. Ranolazine reduces neuronal excitability by interacting with inactivated States of brain sodium channels.
Mol. Pharmacol., 2014 Jan , 85 (162-74).

330

Baroni D et al. Antisense-mediated post-transcriptional silencing of SCN1B gene modulates sodium channel functional expression.
Biol. Cell, 2014 Jan , 106 (13-29).

331

Chen HP et al. Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury.
Neurochem. Res., 2014 Jan , 39 (76-83).

332

Shorer Z et al. A novel mutation in SCN9A in a child with congenital insensitivity to pain.
Pediatr. Neurol., 2014 Jan , 50 (73-6).

333

Matsushita N et al. Nicorandil improves electrical remodelling, leading to the prevention of electrically induced ventricular tachyarrhythmia in a mouse model of desmin-related cardiomyopathy.
Clin. Exp. Pharmacol. Physiol., 2014 Jan , 41 (89-97).

334

Gajewiak J et al. A disulfide tether stabilizes the block of sodium channels by the conotoxin μO§-GVIIJ.
Proc. Natl. Acad. Sci. U.S.A., 2014 Feb 18 , 111 (2758-63).

335

Huang XJ et al. Blockage of the upregulation of voltage-gated sodium channel nav1.3 improves outcomes after experimental traumatic brain injury.
J. Neurotrauma, 2014 Feb 15 , 31 (346-57).

336

Tamura R et al. Up-regulation of NaV1.7 sodium channels expression by tumor necrosis factor-α in cultured bovine adrenal chromaffin cells and rat dorsal root ganglion neurons.
Anesth. Analg., 2014 Feb , 118 (318-24).

337

Dulong C et al. The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.
Int. J. Oncol., 2014 Feb , 44 (539-47).

338

Muroi Y et al. Targeting voltage gated sodium channels NaV1.7, Na V1.8, and Na V1.9 for treatment of pathological cough.
Lung, 2014 Feb , 192 (15-20).

339

Mukai M et al. Evaluation of behavior and expression of NaV1.7 in dorsal root ganglia after sciatic nerve compression and application of nucleus pulposus in rats.
Eur Spine J, 2014 Feb , 23 (463-8).

340

Vanoye CG et al. Novel SCN3A variants associated with focal epilepsy in children.
Neurobiol. Dis., 2014 Feb , 62 (313-22).

341

Cheng KI et al. Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats.
Eur J Pain, 2014 Feb , 18 (162-73).

342

Xu L et al. [Expression of voltage gated sodium channel Nav1.9 in experimental pulpal lesions in the rats].
Zhonghua Kou Qiang Yi Xue Za Zhi, 2014 Feb , 49 (95-100).

343

Wei P et al. Jingzhaotoxin-35, a novel gating-modifier toxin targeting both Nav1.5 and Kv2.1 channels.
Toxicon, 2014 Dec 15 , 92 (90-6).

344

Schroder EA et al. Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.
Am. J. Physiol. Heart Circ. Physiol., 2014 Dec 15 , 307 (H1777-85).

345

Tang C et al. The tarantula toxin jingzhaotoxin-XI (κ-theraphotoxin-Cj1a) regulates the activation and inactivation of the voltage-gated sodium channel Nav1.5.
Toxicon, 2014 Dec 15 , 92 (6-13).

346

Savio-Galimberti E et al. Atrial Fibrillation and SCN5A Variants.
Card Electrophysiol Clin, 2014 Dec 1 , 6 (741-748).

347

Corrochano S et al. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
Brain, 2014 Dec , 137 (3171-85).

348

Swan H et al. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.
Circ Cardiovasc Genet, 2014 Dec , 7 (771-81).

349

Yang Q et al. Persistent pain after spinal cord injury is maintained by primary afferent activity.
J. Neurosci., 2014 Aug 6 , 34 (10765-9).

350

Huang WF et al. Role of sodium channels in the spontaneous excitability of early embryonic cardiomyocytes.
Chin J Physiol, 2014 Aug 31 , 57 (188-97).

351

Magdaleno-Méndez A et al. Ghrelin increases growth hormone production and functional expression of NaV1.1 and Na V1.2 channels in pituitary somatotropes.
Endocrine, 2014 Aug 24 , ().

352

Lin X et al. Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts.
J. Physiol. (Lond.), 2014 Aug 15 , ().

353

Park JH et al. Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels.
J. Med. Chem., 2014 Aug 14 , 57 (6623-31).

354

Spencer CI et al. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.
Stem Cell Reports, 2014 Aug 12 , 3 (269-81).

355

Bouafia A et al. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Neuropathol. Appl. Neurobiol., 2014 Aug , 40 (579-90).

356

Zhang H et al. Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes.
Neurosci Bull, 2014 Aug , 30 (697-710).

357

Liu Y et al. Synthesis and analgesic effects of μ-TRTX-Hhn1b on models of inflammatory and neuropathic pain.
Toxins (Basel), 2014 Aug , 6 (2363-78).

358

Alexandrou AJ et al. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
J. Physiol. Pharmacol., 2014 Aug , 65 (511-23).

359

Mi W et al. Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis.
J. Gen. Physiol., 2014 Aug , 144 (137-45).

360

Beckermann TM et al. Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
Heart Rhythm, 2014 Aug , 11 (1446-53).

361

Pambrun T et al. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Heart Rhythm, 2014 Aug , 11 (1393-400).

362

Makinson CD et al. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance.
Neurobiol. Dis., 2014 Aug , 68 (16-25).

363

Osorio N et al. Specialized functions of Nav1.5 and Nav1.9 channels in electrogenesis of myenteric neurons in intact mouse ganglia.
J. Neurosci., 2014 Apr 9 , 34 (5233-44).

364

Brauner JM et al. Risperidone inhibits voltage-gated sodium channels.
Eur. J. Pharmacol., 2014 Apr 5 , 728 (100-6).

365

Weller CM et al. Two novel SCN1A mutations identified in families with familial hemiplegic migraine.
Cephalalgia, 2014 Apr 4 , ().

366

Themistocleous AC et al. The clinical approach to small fibre neuropathy and painful channelopathy.
Pract Neurol, 2014 Apr 28 , ().

367

Senatore A et al. T-type channels become highly permeable to sodium ions using an alternative extracellular turret region (S5-P) outside the selectivity filter.
J. Biol. Chem., 2014 Apr 25 , 289 (11952-69).

368

Zhao H et al. [Localization and expression pattern of MDM2 in axon initial segments of neuron in rodent brain].
Sheng Li Xue Bao, 2014 Apr 25 , 66 (107-17).

369

Yuan L et al. Investigations of the Navβ1b sodium channel subunit in human ventricle; functional characterization of the H162P Brugada syndrome mutant.
Am. J. Physiol. Heart Circ. Physiol., 2014 Apr 15 , 306 (H1204-12).

370

Abriel H et al. Unexpected α-α interactions with NaV1.5 genetic variants in Brugada syndrome.
Circ Cardiovasc Genet, 2014 Apr 1 , 7 (97-9).

371

Sadamasu A et al. Upregulation of NaV1.7 in dorsal root ganglia after intervertebral disc injury in rats.
Spine, 2014 Apr 1 , 39 (E421-6).

372

Groome JR et al. NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery.
Brain, 2014 Apr , 137 (998-1008).

373

Senatore A et al. Cav3 T-type channels: regulators for gating, membrane expression, and cation selectivity.
Pflugers Arch., 2014 Apr , 466 (645-60).

374

Kruse M et al. TRPM4 channels in the cardiovascular system.
Curr Opin Pharmacol, 2014 Apr , 15 (68-73).

375

Zhao Z et al. Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing.
Cardiovasc Drugs Ther, 2014 Apr , 28 (137-43).

376

Vasylyev DV et al. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.
J. Neurophysiol., 2014 Apr , 111 (1429-43).

377

Delaney JT et al. Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.
Europace, 2014 Apr , 16 (485-90).

378

Sivagangabalan G et al. Regional ion channel gene expression heterogeneity and ventricular fibrillation dynamics in human hearts.
PLoS ONE, 2014 , 9 (e82179).

379

Liu Z et al. Repeated functional convergent effects of NaV1.7 on acid insensitivity in hibernating mammals.
Proc. Biol. Sci., 2014 , 281 (20132950).

380

Moreau A et al. Biophysics, pathophysiology, and pharmacology of ion channel gating pores.
Front Pharmacol, 2014 , 5 (53).

381

Inada S et al. Importance of gradients in membrane properties and electrical coupling in sinoatrial node pacing.
PLoS ONE, 2014 , 9 (e94565).

382

Laedermann CJ et al. Ubiquitylation of voltage-gated sodium channels.
Handb Exp Pharmacol, 2014 , 221 (231-50).

383

Meng E et al. Screening for voltage-gated sodium channel interacting peptides.
Sci Rep, 2014 , 4 (4569).

384

Rudokas MW et al. The Xenopus oocyte cut-open vaseline gap voltage-clamp technique with fluorometry.
J Vis Exp, 2014 , ().

385

Hsieh JY et al. Rapid development of Purkinje cell excitability, functional cerebellar circuit, and afferent sensory input to cerebellum in zebrafish.
Front Neural Circuits, 2014 , 8 (147).

386

Thakur M et al. Defining the nociceptor transcriptome.
Front Mol Neurosci, 2014 , 7 (87).

387

Wang C et al. Structural basis of diverse membrane target recognitions by ankyrins.
Elife, 2014 , 3 ().

388

Neishabouri A et al. Saltatory conduction in unmyelinated axons: clustering of Na(+) channels on lipid rafts enables micro-saltatory conduction in C-fibers.
Front Neuroanat, 2014 , 8 (109).

389

Luo J et al. Molecular surface of JZTX-V (β-Theraphotoxin-Cj2a) interacting with voltage-gated sodium channel subtype NaV1.4.
Toxins (Basel), 2014 , 6 (2177-93).

390

Jones DK et al. Proton modulation of cardiac I Na: a potential arrhythmogenic trigger.
Handb Exp Pharmacol, 2014 , 221 (169-81).

391

Lampert A et al. Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents.
Handb Exp Pharmacol, 2014 , 221 (91-110).

392

Vreeker A et al. Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart.
PLoS ONE, 2014 , 9 (e94722).

393

Zhao R et al. PKC-NF-κB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons.
Biosci. Rep., 2014 , 34 ().

394

Belkouch M et al. Functional up-regulation of Nav1.8 sodium channel in Aβ afferent fibers subjected to chronic peripheral inflammation.
J Neuroinflammation, 2014 , 11 (45).

395

Fontes MS et al. Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophy.
PLoS ONE, 2014 , 9 (e87226).

396

He B et al. Functional expression of Rat Nav1.6 voltage-gated sodium channels in HEK293 cells: modulation by the auxiliary β1 subunit.
PLoS ONE, 2014 , 9 (e85188).

397

Zimmer T et al. Voltage-gated sodium channels in the mammalian heart.
Glob Cardiol Sci Pract, 2014 , 2014 (449-63).

398

Kim DY et al. The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells.
Neurodegener Dis, 2014 , 13 (64-8).

399

Korogod SM et al. Dynamic excitation states and firing patterns are controlled by sodium channel kinetics in myenteric neurons: a simulation study.
Channels (Austin), 2014 , 8 (536-43).

400

Cao J et al. Intrathecal injection of fluorocitric acid inhibits the activation of glial cells causing reduced mirror pain in rats.
BMC Anesthesiol, 2014 , 14 (119).

401

Mahdavi S et al. Systematic study of binding of μ-conotoxins to the sodium channel NaV1.4.
Toxins (Basel), 2014 , 6 (3454-70).

402

Liu XD et al. Functional upregulation of nav1.8 sodium channels on the membrane of dorsal root Ganglia neurons contributes to the development of cancer-induced bone pain.
PLoS ONE, 2014 , 9 (e114623).

403

Driffort V et al. Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.
Mol. Cancer, 2014 , 13 (264).

404

Amarouch MY et al. Functional interaction between S1 and S4 segments in voltage-gated sodium channels revealed by human channelopathies.
Channels (Austin), 2014 , 8 (414-20).

405

Wang ZJ et al. Resibufogenin and cinobufagin activate central neurons through an ouabain-like action.
PLoS ONE, 2014 , 9 (e113272).

406

Béziau DM et al. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
Basic Res. Cardiol., 2014 , 109 (446).

407

Lakomá J et al. Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice.
PLoS ONE, 2014 , 9 (e108641).

408

Christidis N et al. Expression of 5-HT3 receptors and TTX resistant sodium channels (Na(V)1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders.
J Headache Pain, 2014 , 15 (63).

409

Gingras J et al. Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain.
PLoS ONE, 2014 , 9 (e105895).

410

Bende NS et al. A distinct sodium channel voltage-sensor locus determines insect selectivity of the spider toxin Dc1a.
Nat Commun, 2014 , 5 (4350).

411

Magot A et al. Focal and abnormally persistent paralysis associated with congenital paramyotonia.
BMJ Case Rep, 2014 , 2014 ().

412

Gabelli SB et al. Regulation of the NaV1.5 cytoplasmic domain by calmodulin.
Nat Commun, 2014 , 5 (5126).

413

Petersson ME et al. Differential axonal conduction patterns of mechano-sensitive and mechano-insensitive nociceptors--a combined experimental and modelling study.
PLoS ONE, 2014 , 9 (e103556).

414

Mahdavi S et al. Molecular dynamics study of binding of µ-conotoxin GIIIA to the voltage-gated sodium channel Na(v)1.4.
PLoS ONE, 2014 , 9 (e105300).

415

Minett MS et al. Significant determinants of mouse pain behaviour.
PLoS ONE, 2014 , 9 (e104458).

416

Chen R et al. Mechanism of μ-conotoxin PIIIA binding to the voltage-gated Na+ channel NaV1.4.
PLoS ONE, 2014 , 9 (e93267).

417

Liu ZR et al. PKA phosphorylation reshapes the pharmacological kinetics of BmK AS, a unique site-4 sodium channel-specific modulator.
Sci Rep, 2014 , 4 (3721).

418

Ricci MT et al. SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.
Sci Rep, 2014 , 4 (6470).

419

Chen W et al. Generation of the SCN1A epilepsy mutation in hiPS cells using the TALEN technique.
Sci Rep, 2014 , 4 (5404).

420

Abdelsayed M et al. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
Channels (Austin), 2013 May-Jun , 7 (146-52).

421

Elkins RC et al. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (112-22).

422

Morissette P et al. The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (137-49).

423

Qu Y et al. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (74-81).

424

Wang GK et al. Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.
Channels (Austin), 2013 Jul-Aug , 7 (263-74).

425

Chiu IM et al. Bacteria activate sensory neurons that modulate pain and inflammation.
Nature, 2013 Sep 5 , 501 (52-7).

426

Ahn HS et al. Differential effect of D623N variant and wild-type Na(v)1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons.
Brain Res., 2013 Sep 5 , 1529 (165-77).

427

Baczkó I et al. Characterization of a novel multi-functional resveratrol derivative for the treatment of atrial fibrillation.
Br. J. Pharmacol., 2013 Sep 18 , ().

428

Chen J et al. Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats.
Neuroscience, 2013 Sep 17 , 248 (469-78).

429

Leipold E et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception.
Nat. Genet., 2013 Sep 15 , ().

430

Pérez-Medina C et al. Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels.
Bioorg. Med. Chem. Lett., 2013 Sep 15 , 23 (5170-3).

431

Hernãndez-Ochoa EO et al. Elevated nuclear Foxo1 suppresses excitability of skeletal muscle fibers.
Am. J. Physiol., Cell Physiol., 2013 Sep 15 , 305 (C643-53).

432

Washburn DG et al. The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore.
Bioorg. Med. Chem. Lett., 2013 Sep 1 , 23 (4979-84).

433

Shryock JC et al. The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.
Cardiovasc. Res., 2013 Sep 1 , 99 (600-11).

434

King JH et al. Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation.
Cardiovasc. Res., 2013 Sep 1 , 99 (751-9).

435

Oliveira EE et al. A residue in the transmembrane segment 6 of domain I in insect and mammalian sodium channels regulate differential sensitivities to pyrethroid insecticides.
Neurotoxicology, 2013 Sep , 38 (42-50).

436

Zhu L et al. Two recombinant α-like scorpion toxins from Mesobuthus eupeus with differential affinity toward insect and mammalian Na(+) channels.
Biochimie, 2013 Sep , 95 (1732-40).

437

Shen KF et al. Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons.
Exp. Neurol., 2013 Sep , 247 (466-75).

438

Lewis AH et al. Interactions among DIV voltage-sensor movement, fast inactivation, and resurgent Na current induced by the NaVβ4 open-channel blocking peptide.
J. Gen. Physiol., 2013 Sep , 142 (191-206).

439

Xiao M et al. FGF14 localization and organization of the axon initial segment.
Mol. Cell. Neurosci., 2013 Sep , 56 (393-403).

440

Qiao X et al. Expression of sodium channel α subunits 1.1, 1.2 and 1.6 in rat hippocampus after kainic acid-induced epilepsy.
Epilepsy Res., 2013 Sep , 106 (17-28).

441

Zhang Q et al. Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL‑1 cardiomyocytes.
Mol Med Rep, 2013 Sep , 8 (780-6).

442

Wu Z et al. Full-length membrane-bound tumor necrosis factor-α acts through tumor necrosis factor receptor 2 to modify phenotype of sensory neurons.
Pain, 2013 Sep , 154 (1778-82).

443

Deuis JR et al. An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways.
Pain, 2013 Sep , 154 (1749-57).

444

Puthussery T et al. NaV1.1 channels in axon initial segments of bipolar cells augment input to magnocellular visual pathways in the primate retina.
J. Neurosci., 2013 Oct 9 , 33 (16045-59).

445

Tao H et al. Analysis of the Interaction of Tarantula Toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the Voltage Sensor of Kv2.1 Uncovers the Molecular Basis for Cross-Activities on Kv2.1 and Nav1.5 Channels.
Biochemistry, 2013 Oct 7 , ().

446

Rowe AH et al. Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin.
Science, 2013 Oct 25 , 342 (441-6).

447

Cestèle S et al. Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.
Proc. Natl. Acad. Sci. U.S.A., 2013 Oct 22 , 110 (17546-51).

448

Yang S et al. Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.
Proc. Natl. Acad. Sci. U.S.A., 2013 Oct 22 , 110 (17534-9).

449

Black JA et al. Noncanonical roles of voltage-gated sodium channels.
Neuron, 2013 Oct 16 , 80 (280-91).

450

Sheets MF et al. Outward stabilization of the voltage sensor in domain II but not domain I speeds inactivation of voltage-gated sodium channels.
Am. J. Physiol. Heart Circ. Physiol., 2013 Oct 15 , 305 (H1213-21).

451

Ma D et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Int. J. Cardiol., 2013 Oct 15 , 168 (5277-86).

452

Beltran-Alvarez P et al. Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel.
FEBS Lett., 2013 Oct 1 , 587 (3159-65).

453

Sandalon S et al. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension.
Exp. Eye Res., 2013 Oct , 115 (47-56).

454

Eleawa SM et al. Effect of testosterone replacement therapy on cardiac performance and oxidative stress in orchidectomized rats.
Acta Physiol (Oxf), 2013 Oct , 209 (136-47).

455

Wu M et al. A naturally occurring amino acid substitution in the voltage-dependent sodium channel selectivity filter affects channel gating.
J. Comp. Physiol. A Neuroethol. Sens. Neural. Behav. Physiol., 2013 Oct , 199 (829-42).

456

Zhang XY et al. Gain-of-function mutations in SCN11A cause familial episodic pain.
Am. J. Hum. Genet., 2013 Nov 7 , 93 (957-66).

457

Su YY et al. KIF5B promotes the forward transport and axonal function of the voltage-gated sodium channel Nav1.8.
J. Neurosci., 2013 Nov 6 , 33 (17884-96).

458

Abbasi S et al. Introducing treatment strategy for cerebellar ataxia in mutant med mice: Combination of acetazolamide and 4-Aminopyridine.
Comput Methods Programs Biomed, 2013 Nov 24 , ().

459

Daou I et al. Remote optogenetic activation and sensitization of pain pathways in freely moving mice.
J. Neurosci., 2013 Nov 20 , 33 (18631-40).

460

Marsman RF et al. Coxsackie and adenovirus receptor (CAR) is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemia.
J. Am. Coll. Cardiol., 2013 Nov 18 , ().

461

Zhao ZQ et al. Chronic itch development in sensory neurons requires BRAF signaling pathways.
J. Clin. Invest., 2013 Nov 1 , 123 (4769-80).

462

Brisson L et al. NaV1.5 Na⁺ channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia.
J. Cell. Sci., 2013 Nov 1 , 126 (4835-42).

463

Jiao J et al. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.
Hum. Mol. Genet., 2013 Nov 1 , 22 (4241-52).

464

Cox JJ et al. No pain, more gain.
Nat. Genet., 2013 Nov , 45 (1271-2).

465

Fedele F et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.
Basic Res. Cardiol., 2013 Nov , 108 (387).

466

Nadrowitz F et al. The distinct effects of lipid emulsions used for "lipid resuscitation" on gating and bupivacaine-induced inhibition of the cardiac sodium channel Nav1.5.
Anesth. Analg., 2013 Nov , 117 (1101-8).

467

Westenbroek RE et al. Localization of sodium channel subtypes in mouse ventricular myocytes using quantitative immunocytochemistry.
J. Mol. Cell. Cardiol., 2013 Nov , 64 (69-78).

468

Koenig X et al. Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile.
Toxicol. Appl. Pharmacol., 2013 May 22 , ().

469

Yang Y et al. Molecular architecture of a sodium channel S6 helix: radial tuning of the voltage-gated sodium channel 1.7 activation gate.
J. Biol. Chem., 2013 May 10 , 288 (13741-7).

470

Groome JR et al. S1-S3 counter charges in the voltage sensor module of a mammalian sodium channel regulate fast inactivation.
J. Gen. Physiol., 2013 May , 141 (601-18).

471

Oakley JC et al. Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.
J. Pharmacol. Exp. Ther., 2013 May , 345 (215-24).

472

Kalezic I et al. In vivo and ex vivo inhibition of spinal nerve ligation-induced ectopic activity by sodium channel blockers correlate to in vitro inhibition of NaV1.7 and clinical efficacy: a pharmacokinetic-pharmacodynamic translational approach.
Pharm. Res., 2013 May , 30 (1409-22).

473

Kendel Y et al. Venomous secretions from marine snails of the Terebridae family target acetylcholine receptors.
Toxins (Basel), 2013 May , 5 (1043-50).

474

Kim JJ et al. Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk.
Am. J. Physiol. Heart Circ. Physiol., 2013 Mar 15 , 304 (H848-60).

475

Estacion M et al. A new Nav1.7 mutation in an erythromelalgia patient.
Biochem. Biophys. Res. Commun., 2013 Mar 1 , 432 (99-104).

476

Luo Y et al. [Inhibitory effect of NaV1.9 gene silencing on proliferation, phagocytosis and migration in RAW264.7 cells].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2013 Mar , 29 (225-8).

477

Yu YQ et al. Activation of tetrodotoxin-resistant sodium channel NaV1.9 in rat primary sensory neurons contributes to melittin-induced pain behavior.
Neuromolecular Med., 2013 Mar , 15 (209-17).

478

Noorman M et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
Heart Rhythm, 2013 Mar , 10 (412-9).

479

Hargus NJ et al. Evidence for a Role of Nav1.6 in Facilitating Increases in Neuronal Hyper-excitability During Epileptogenesis.
J. Neurophysiol., 2013 Jun 5 , ().

480

Driscoll HE et al. Pumilio-2 regulates translation of Nav1.6 to mediate homeostasis of membrane excitability.
J. Neurosci., 2013 Jun 5 , 33 (9644-54).

481

Gao B et al. Expression and secretion of functional recombinant μO-conotoxin MrVIB-His-tag in Escherichia coli.
Toxicon, 2013 Jun 27 , 72C (81-89).

482

Morris GM et al. Characterisation of a Right Atrial Subsidiary Pacemaker and acceleration of the pacing rate by HCN over-expression.
Cardiovasc. Res., 2013 Jun 19 , ().

483

Minassian NA et al. Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin, Huwentoxin-IV (μ-TRTX-Hh2a).
J. Biol. Chem., 2013 Jun 12 , ().

484

Rahgozar K et al. Mediation of protection and recovery from experimental autoimmune encephalomyelitis by macrophages expressing the human voltage-gated sodium channel NaV1.5.
J. Neuropathol. Exp. Neurol., 2013 Jun , 72 (489-504).

485

Liang L et al. Protein kinase B/Akt is required for complete Freund's adjuvant-induced upregulation of Nav1.7 and Nav1.8 in primary sensory neurons.
J Pain, 2013 Jun , 14 (638-47).

486

Revell JD et al. Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena.
Peptides, 2013 Jun , 44 (40-6).

487

Bender AC et al. Focal Scn1a knockdown induces cognitive impairment without seizures.
Neurobiol. Dis., 2013 Jun , 54 (297-307).

488

Cregg R et al. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.
Neuromolecular Med., 2013 Jun , 15 (265-78).

489

Nilsson MF et al. Comparative effects of sodium channel blockers in short term rat whole embryo culture.
Toxicol. Appl. Pharmacol., 2013 Jul 8 , ().

490

Shavkunov AS et al. The Fibroblast Growth Factor 14{middle dot}Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3).
J. Biol. Chem., 2013 Jul 5 , 288 (19370-85).

491

Korkmaz S et al. Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats.
J. Am. Coll. Cardiol., 2013 Jul 23 , 62 (340-9).

492

Jones DK et al. Extracellular protons inhibit charge immobilization in the cardiac voltage-gated sodium channel.
Biophys. J., 2013 Jul 2 , 105 (101-7).

493

Ravens U et al. Atrial selectivity of antiarrhythmic drugs.
J. Physiol. (Lond.), 2013 Jul 16 , ().

494

Du Y et al. Molecular evidence for dual pyrethroid-receptor sites on a mosquito sodium channel.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 16 , 110 (11785-90).

495

McCormack K et al. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 16 , 110 (E2724-32).

496

Liu Z et al. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
J. Biol. Chem., 2013 Jul 12 , 288 (20392-403).

497

Takanari H et al. Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue.
Cardiovasc. Res., 2013 Jul 1 , 99 (203-14).

498

Tsunozaki M et al. A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain.
J. Physiol. (Lond.), 2013 Jul 1 , 591 (3325-40).

499

Gillet L et al. NaV1.5 and interacting proteins in human arrhythmogenic cardiomyopathy.
Future Cardiol, 2013 Jul , 9 (467-70).

500

Purcell RH et al. Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice.
Psychopharmacology (Berl.), 2013 Jul , 228 (263-70).

501

Walewska A et al. Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.
Eur J Med Chem, 2013 Jul , 65 (144-50).

502

Jiang N et al. Molecular and cellular influences of permethrin on mammalian nociceptors at physiological temperatures.
Neurotoxicology, 2013 Jul , 37 (207-19).

503

Galloway C et al. Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes.
Cytokine, 2013 Jul , 63 (1-5).

504

Waxman SG Painful Na-channelopathies: an expanding universe.
Trends Mol Med, 2013 Jul , 19 (406-9).

505

Xu X et al. Abnormal changes in voltage-gated sodium channels Na(V)1.1, Na(V)1.2, Na(V)1.3, Na(V)1.6 and in calmodulin/calmodulin-dependent protein kinase II, within the brains of spontaneously epileptic rats and tremor rats.
Brain Res. Bull., 2013 Jul , 96 (1-9).

506

Zhang Q et al. [Desmoplakin expression silencing affects cardiac voltage-gated sodium channel Nav1.5 in HL-1 cells].
Nan Fang Yi Ke Da Xue Xue Bao, 2013 Jul , 33 (983-9).

507

Norinder U et al. QSAR investigation of NaV1.7 active compounds using the SVM/Signature approach and the Bioclipse Modeling platform.
Bioorg. Med. Chem. Lett., 2013 Jan 1 , 23 (261-3).

508

Huang XJ et al. Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats.
J. Neurotrauma, 2013 Jan 1 , 30 (39-46).

509

Ramachandra R et al. NaV1.8 channels are expressed in large, as well as small, diameter sensory afferent neurons.
Channels (Austin), 2013 Jan 1 , 7 (34-7).

510

Persson AK et al. Neuropathy-associated Nav1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons.
Ann. Neurol., 2013 Jan , 73 (140-5).

511

Suter MR et al. Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state.
Anesthesiology, 2013 Jan , 118 (160-72).

512

Dutton SB et al. Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.
Neurobiol. Dis., 2013 Jan , 49 (211-20).

513

Ito S et al. Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment.
Neurobiol. Dis., 2013 Jan , 49 (29-40).

514

Zhang JL et al. Gabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing expression level of Nav1.7 and p-ERK1/2 in DRG neurons.
Brain Res., 2013 Feb 1 , 1493 (13-8).

515

Calloe K et al. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
Circ Arrhythm Electrophysiol, 2013 Feb , 6 (177-84).

516

Vanoye CG et al. Mechanism of sodium channel NaV1.9 potentiation by G-protein signaling.
J. Gen. Physiol., 2013 Feb , 141 (193-202).

517

Desaphy JF et al. Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
Mol. Pharmacol., 2013 Feb , 83 (406-15).

518

Zhang LM et al. [Association between mutations of SCN9A gene and pain related to Parkinsonism].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2013 Feb , 30 (17-20).

519

Harris RA et al. Human metastable epiallele candidates link to common disorders.
Epigenetics, 2013 Feb , 8 (157-63).

520

Núñez L et al. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
Heart Rhythm, 2013 Feb , 10 (264-72).

521

Yu J et al. SCN5A mutation in Chinese patients with arrhythmogenic right ventricular dysplasia.
Herz, 2013 Dec 8 , ().

522

Tanzi S et al. Ion channel recordings on an injection-molded polymer chip.
Lab Chip, 2013 Dec 21 , 13 (4784-93).

523

Gilchrist J et al. Crystallographic insights into sodium-channel modulation by the β4 subunit.
Proc. Natl. Acad. Sci. U.S.A., 2013 Dec 17 , 110 (E5016-24).

524

Ogiwara I et al. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.
Hum. Mol. Genet., 2013 Dec 1 , 22 (4784-804).

525

Staunton CA et al. Ion channels and osteoarthritic pain: potential for novel analgesics.
Curr Pain Headache Rep, 2013 Dec , 17 (378).

526

Wu F et al. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
Brain, 2013 Dec , 136 (3766-74).

527

Volkers L et al. Febrile temperatures unmask biophysical defects in Nav1.1 epilepsy mutations supportive of seizure initiation.
J. Gen. Physiol., 2013 Dec , 142 (641-53).

528

Doppler K et al. [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].
Nervenarzt, 2013 Dec , 84 (1428-35).

529

Campbell TM et al. Functional expression of the voltage-gated sodium channel, Nav1.7, underlies epidermal growth factor-mediated invasion in human [R1.S1] non-small cell lung cancer cells.
J. Cell. Sci., 2013 Aug 28 , ().

530

Huang J et al. Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.
J. Neurosci., 2013 Aug 28 , 33 (14087-97).

531

Dustrude ET et al. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
J. Biol. Chem., 2013 Aug 23 , 288 (24316-31).

532

Bradley E et al. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2013 Aug 15 , 305 (C427-35).

533

Herren AW et al. Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias.
Am. J. Physiol. Heart Circ. Physiol., 2013 Aug 15 , 305 (H431-45).

534

Stevens M et al. Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
J. Neuroimmunol., 2013 Aug 15 , 261 (21-8).

535

Liu S et al. Altered PKA modulation in the Nav1.1 epilepsy variant I1656M.
J. Neurophysiol., 2013 Aug 14 , ().

536

Li A et al. Genetic biomarkers in Brugada syndrome.
Biomark Med, 2013 Aug , 7 (535-46).

537

Kamiński K et al. Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V.
Eur J Med Chem, 2013 Aug , 66 (12-21).

538

Kaufmann SG et al. Distribution and function of sodium channel subtypes in human atrial myocardium.
J. Mol. Cell. Cardiol., 2013 Aug , 61 (133-41).

539

Abbas N et al. The scorpion toxin Amm VIII induces pain hypersensitivity through gain-of-function of TTX-sensitive Na⁺ channels.
Pain, 2013 Aug , 154 (1204-15).

540

Xie W et al. Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia.
Pain, 2013 Aug , 154 (1170-80).

541

Maury P et al. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
J Interv Card Electrophysiol, 2013 Aug , 37 (131-40).

542

Toischer K et al. Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease.
J. Mol. Cell. Cardiol., 2013 Aug , 61 (111-22).

543

Rhett JM et al. The perinexus: sign-post on the path to a new model of cardiac conduction?
Trends Cardiovasc. Med., 2013 Aug , 23 (222-8).

544

Mourão CB et al. Characterization of a novel peptide toxin from Acanthoscurria paulensis spider venom: a distinct cysteine assignment to the HWTX-II family.
Biochemistry, 2013 Apr 9 , 52 (2440-52).

545

Nemoto T et al. Endothelin-1-induced down-regulation of NaV1.7 expression in adrenal chromaffin cells: attenuation of catecholamine secretion and tau dephosphorylation.
FEBS Lett., 2013 Apr 2 , 587 (898-905).

546

Corbett BF et al. Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease.
J. Neurosci., 2013 Apr 17 , 33 (7020-6).

547

Crotti L et al. Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA, 2013 Apr 10 , 309 (1473-82).

548

Kalume F et al. Sudden unexpected death in a mouse model of Dravet syndrome.
J. Clin. Invest., 2013 Apr 1 , 123 (1798-808).

549

Shy D et al. Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model.
Biochim. Biophys. Acta, 2013 Apr , 1833 (886-94).

550

Black JA et al. Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Mult. Scler., 2013 Apr , 19 (532-42).

551

Heimann D et al. Linkage between Increased Nociception and Olfaction via a SCN9A Haplotype.
PLoS ONE, 2013 , 8 (e68654).

552

Kramer J et al. MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes.
Sci Rep, 2013 , 3 (2100).

553

Hegyi B et al. Selectivity problems with drugs acting on cardiac Na⁺ and Ca²⁺ channels.
Curr. Med. Chem., 2013 , 20 (2552-71).

554

Lübkemeier I et al. Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels.
Basic Res. Cardiol., 2013 , 108 (348).

555

Goldschen-Ohm MP et al. Multiple pore conformations driven by asynchronous movements of voltage sensors in a eukaryotic sodium channel.
Nat Commun, 2013 , 4 (1350).

556

Ishikawa T et al. Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5.
Circ. J., 2013 , 77 (959-67).

557

Zschüntzsch J et al. Heterologous expression of a glial Kir channel (KCNJ10) in a neuroblastoma spinal cord (NSC-34) cell line.
Physiol Res, 2013 , 62 (95-105).

558

Atkinson AJ et al. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc, 2013 , 2 (e000246).

559

Ma Z et al. Direct Evidence that Scorpion α-Toxins (Site-3) Modulate Sodium Channel Inactivation by Hindrance of Voltage-Sensor Movements.
PLoS ONE, 2013 , 8 (e77758).

560

Bird EV et al. Correlation of Nav1.8 and Nav1.9 sodium channel expression with neuropathic pain in human subjects with lingual nerve neuromas.
Mol Pain, 2013 , 9 (52).

561

Zhang Z et al. Kinetic model of Nav1.5 channel provides a subtle insight into slow inactivation associated excitability in cardiac cells.
PLoS ONE, 2013 , 8 (e64286).

562

Zeng Z et al. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
PLoS ONE, 2013 , 8 (e78382).

563

Dun W et al. Ankyrin-G participates in INa remodeling in myocytes from the border zones of infarcted canine heart.
PLoS ONE, 2013 , 8 (e78087).

564

Auerbach DS et al. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome.
PLoS ONE, 2013 , 8 (e77843).

565

Fujii M et al. New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon single action potential.
J. Pharmacol. Sci., 2013 , 123 (147-58).

566

Nakatani Y et al. Effect of lamotrigine on Na(v)1.4 voltage-gated sodium channels.
J. Pharmacol. Sci., 2013 , 123 (203-6).

567

Weibel R et al. Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.
PLoS ONE, 2013 , 8 (e74706).

568

Zhou X et al. Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats.
PLoS ONE, 2013 , 8 (e74390).

569

Baraban SC et al. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.
Nat Commun, 2013 , 4 (2410).

570

Reddy Chichili VP et al. Structural basis for the modulation of the neuronal voltage-gated sodium channel NaV1.6 by calmodulin.
Sci Rep, 2013 , 3 (2435).

571

Black JA et al. NaV1.7: stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus.
Mol Pain, 2013 , 9 (39).

572

Zumhagen S et al. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
PLoS ONE, 2013 , 8 (e67963).

573

Rong M et al. Native pyroglutamation of huwentoxin-IV: a post-translational modification that increases the trapping ability to the sodium channel.
PLoS ONE, 2013 , 8 (e65984).

574

Dolz-Gaitón P et al. Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family.
PLoS ONE, 2013 , 8 (e81493).

575

Islas AA et al. Identification of Navβ1 residues involved in the modulation of the sodium channel Nav1.4.
PLoS ONE, 2013 , 8 (e81995).

576

Biswas S et al. Mechanisms of a human skeletal myotonia produced by mutation in the C-terminus of NaV1.4: is Ca2+ regulation defective?
PLoS ONE, 2013 , 8 (e81063).

577

Tsantoulas C et al. Probing functional properties of nociceptive axons using a microfluidic culture system.
PLoS ONE, 2013 , 8 (e80722).

578

Liang J et al. Effect of amitriptyline on tetrodotoxin-resistant Nav1.9 currents in nociceptive trigeminal neurons.
Mol Pain, 2013 , 9 (31).

579

Cejudo-Román A et al. The voltage-gated sodium channel nav1.8 is expressed in human sperm.
PLoS ONE, 2013 , 8 (e76084).

580

Bourdin CM et al. Intron retention in mRNA encoding ancillary subunit of insect voltage-gated sodium channel modulates channel expression, gating regulation and drug sensitivity.
PLoS ONE, 2013 , 8 (e67290).

581

Kuang Z et al. Mammalian neuronal sodium channel blocker μ-conotoxin BuIIIB has a structured N-terminus that influences potency.
ACS Chem. Biol., 2013 , 8 (1344-51).

582

Durek T et al. Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1.
ACS Chem. Biol., 2013 , 8 (1215-22).

583

Fatima A et al. The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.
PLoS ONE, 2013 , 8 (e83005).

584

Zhang Y et al. Effects of (-)-gallocatechin-3-gallate on tetrodotoxin-resistant voltage-gated sodium channels in rat dorsal root ganglion neurons.
Int J Mol Sci, 2013 , 14 (9779-89).

585

Lossin C et al. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome.
Neurology, 2012 Sep 4 , 79 (1033-40).

586

Chatelier A et al. A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts.
J. Physiol. (Lond.), 2012 Sep 1 , 590 (4307-19).

587

Nozaki C et al. δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.
J. Pharmacol. Exp. Ther., 2012 Sep , 342 (799-807).

588

Jakob A et al. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Klin Padiatr, 2012 Sep , 224 (309-12).

589

Rivara M et al. Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.
Bioorg. Med. Chem. Lett., 2012 Oct 15 , 22 (6401-4).

590

Song W et al. The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity.
J. Physiol. (Lond.), 2012 Oct 15 , 590 (5123-39).

591

Teramoto N et al. Resurgent-like currents in mouse vas deferens myocytes are mediated by NaV1.6 voltage-gated sodium channels.
Pflugers Arch., 2012 Nov , 464 (493-502).

592

Qiu F et al. Increased expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 within dorsal root ganglia in a rat model of bone cancer pain.
Neurosci. Lett., 2012 Mar 23 , 512 (61-6).

593

Saucedo AL et al. Solution structure of native and recombinant expressed toxin CssII from the venom of the scorpion Centruroides suffusus suffusus, and their effects on Nav1.5 sodium channels.
Biochim. Biophys. Acta, 2012 Mar , 1824 (478-87).

594

Tao R et al. [Expression of Nav1.8 in human dental pulp].
Zhonghua Kou Qiang Yi Xue Za Zhi, 2012 Mar , 47 (177-81).

595

Catalano A et al. An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite.
Drug Metab Lett, 2012 Jun 1 , 6 (124-8).

596

Liu P et al. Modulation of neuronal sodium channels by the sea anemone peptide BDS-I.
J. Neurophysiol., 2012 Jun , 107 (3155-67).

597

Liu ZR et al. Pharmacological kinetics of BmK AS, a sodium channel site 4-specific modulator on Nav1.3.
Neurosci Bull, 2012 Jun , 28 (209-21).

598

Park JH et al. Cysteine racemization during the Fmoc solid phase peptide synthesis of the Nav1.7-selective peptide--protoxin II.
J. Pept. Sci., 2012 Jul , 18 (442-8).

599

Marionneau C et al. Mass spectrometry-based identification of native cardiac Nav1.5 channel α subunit phosphorylation sites.
J. Proteome Res., 2012 Dec 7 , 11 (5994-6007).

600

Sierra Bello O et al. In silico docking reveals possible Riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy.
J. Theor. Biol., 2012 Dec 21 , 315 (53-63).

601

Kim YS et al. Expression of transient receptor potential ankyrin 1 in human dental pulp.
J Endod, 2012 Aug , 38 (1087-92).

602

Song W et al. Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.
Pediatr Cardiol, 2012 Aug , 33 (943-9).

603

Gao XF et al. Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels.
PLoS ONE, 2012 , 7 (e49384).

604

Black JA et al. Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn.
Mol Pain, 2012 , 8 (82).

605

Akiyama M et al. Dravet syndrome: a genetic epileptic disorder.
Acta Med. Okayama, 2012 , 66 (369-76).

606

Holliday KL et al. The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility.
Mol Pain, 2012 , 8 (72).

607

Klinger AB et al. Sea-anemone toxin ATX-II elicits A-fiber-dependent pain and enhances resurgent and persistent sodium currents in large sensory neurons.
Mol Pain, 2012 , 8 (69).

608

Due MR et al. Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling.
J Neuroinflammation, 2012 , 9 (200).

609

Kao DJ et al. CC chemokine ligand 2 upregulates the current density and expression of TRPV1 channels and Nav1.8 sodium channels in dorsal root ganglion neurons.
J Neuroinflammation, 2012 , 9 (189).

610

O'Reilly AO et al. Bisphenol A binds to the local anesthetic receptor site to block the human cardiac sodium channel.
PLoS ONE, 2012 , 7 (e41667).

611

Ito A et al. Anti-hyperalgesic effects of calcitonin on neuropathic pain interacting with its peripheral receptors.
Mol Pain, 2012 , 8 (42).

612

Mert T et al. Antinociceptive activities of lidocaine and the nav1.8 blocker a803467 in diabetic rats.
J. Am. Assoc. Lab. Anim. Sci., 2012 , 51 (579-85).

613

Cheng J et al. LQTS-associated mutation A257G in α1-syntrophin interacts with the intragenic variant P74L to modify its biophysical phenotype.
Cardiogenetics, 2011 Oct 25 , 1 ().